Andrew Ratz
Vermogen: 161 149 $ op 31-05-2026
Vermogen: 161 149 $ op 31-05-2026
Dr. Andrew Ratz is a Chief Technical Operations Officer at Neurocrine Biosciences, Inc. Dr. Ratz was previously employed as a Senior Vice President & Head-Drug Delivery by Eli Lilly & Co. He received his undergraduate degree from Indiana University and a doctorate degree from Harvard University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2026 | 1.018 ( 0% ) | 161 149 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 17-03-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau